Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 22 entries
Sorted by: Best Match Show Resources per page
Unexpected depletion in plasma choline and phosphatidylcholine concentrations in a pregnant woman with bipolar affective disorder being treated with lithuim, haloperidol and benztropine: a case report.

Journal of medical case reports

Gossell-Williams M, Fletcher H, Zeisel SH.
PMID: 18289387
J Med Case Rep. 2008 Feb 20;2:55. doi: 10.1186/1752-1947-2-55.

INTRODUCTION: Patients with bipolar affective disorder can be effectively managed with pharmacological intervention. This case report describes a pregnant woman with a ten-year history of bipolar affective disorder that was being treated with lithium, haloperidol and benztropine.CASE PRESENTATION: The...

Cite
Gossell-Williams M, Fletcher H, Zeisel SH. Unexpected depletion in plasma choline and phosphatidylcholine concentrations in a pregnant woman with bipolar affective disorder being treated with lithuim, haloperidol and benztropine: a case report. J Med Case Rep. 2008;2:55doi: 10.1186/1752-1947-2-55.
Gossell-Williams, M., Fletcher, H., & Zeisel, S. H. (2008). Unexpected depletion in plasma choline and phosphatidylcholine concentrations in a pregnant woman with bipolar affective disorder being treated with lithuim, haloperidol and benztropine: a case report. Journal of medical case reports, 255. https://doi.org/10.1186/1752-1947-2-55
Gossell-Williams, Maxine, et al. "Unexpected depletion in plasma choline and phosphatidylcholine concentrations in a pregnant woman with bipolar affective disorder being treated with lithuim, haloperidol and benztropine: a case report." Journal of medical case reports vol. 2 (2008): 55. doi: https://doi.org/10.1186/1752-1947-2-55
Gossell-Williams M, Fletcher H, Zeisel SH. Unexpected depletion in plasma choline and phosphatidylcholine concentrations in a pregnant woman with bipolar affective disorder being treated with lithuim, haloperidol and benztropine: a case report. J Med Case Rep. 2008 Feb 20;2:55. doi: 10.1186/1752-1947-2-55. PMID: 18289387; PMCID: PMC2265726.
Copy Download .nbib Format: NLM
Relationship between extrapyramidal symptoms and serum anticholinergic levels in treated chronic schizophrenics.

Journal of psychopharmacology (Oxford, England)

Bamrah JS, Krska J, Soni SD.
PMID: 22159668
J Psychopharmacol. 1988 Jan;2(1):39-46. doi: 10.1177/026988118800200107.

Serum anticholinergic levels were measured by radioreceptor assay (RRA) in schizophrenic patients treated for drug-induced Parkinsonism; 68 patients stabilized on a single neuroleptic and an anticholinergic antiparkinsonian agent (benzhexol, benztropine or procyclidine) were assessed using the extrapyramidal side effects...

Cite
Bamrah JS, Krska J, Soni SD. Relationship between extrapyramidal symptoms and serum anticholinergic levels in treated chronic schizophrenics. J Psychopharmacol. 1988;2(1):39-46doi: 10.1177/026988118800200107.
Bamrah, J. S., Krska, J., & Soni, S. D. (1988). Relationship between extrapyramidal symptoms and serum anticholinergic levels in treated chronic schizophrenics. Journal of psychopharmacology (Oxford, England), 2(1), 39-46. https://doi.org/10.1177/026988118800200107
Bamrah, J S, et al. "Relationship between extrapyramidal symptoms and serum anticholinergic levels in treated chronic schizophrenics." Journal of psychopharmacology (Oxford, England) vol. 2,1 (1988): 39-46. doi: https://doi.org/10.1177/026988118800200107
Bamrah JS, Krska J, Soni SD. Relationship between extrapyramidal symptoms and serum anticholinergic levels in treated chronic schizophrenics. J Psychopharmacol. 1988 Jan;2(1):39-46. doi: 10.1177/026988118800200107. PMID: 22159668.
Copy Download .nbib Format: NLM
Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia-Key Differences in Pathophysiology and Clinical Management.

Neurology and therapy

Ward KM, Citrome L.
PMID: 30027457
Neurol Ther. 2018 Dec;7(2):233-248. doi: 10.1007/s40120-018-0105-0. Epub 2018 Jul 19.

INTRODUCTION: Drug-induced parkinsonism (DIP) and tardive dyskinesia (TD) are stigmatizing movement disorders associated with exposure to dopamine receptor blocking agents such as antipsychotics, but they differ in their pathophysiology and clinical management. Treatment for one may worsen the other,...

Cite
Ward KM, Citrome L. Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia-Key Differences in Pathophysiology and Clinical Management. Neurol Ther. 2018;7(2):233-248doi: 10.1007/s40120-018-0105-0.
Ward, K. M., & Citrome, L. (2018). Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia-Key Differences in Pathophysiology and Clinical Management. Neurology and therapy, 7(2), 233-248. https://doi.org/10.1007/s40120-018-0105-0
Ward, Kristen M, and Citrome, Leslie. "Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia-Key Differences in Pathophysiology and Clinical Management." Neurology and therapy vol. 7,2 (2018): 233-248. doi: https://doi.org/10.1007/s40120-018-0105-0
Ward KM, Citrome L. Antipsychotic-Related Movement Disorders: Drug-Induced Parkinsonism vs. Tardive Dyskinesia-Key Differences in Pathophysiology and Clinical Management. Neurol Ther. 2018 Dec;7(2):233-248. doi: 10.1007/s40120-018-0105-0. Epub 2018 Jul 19. PMID: 30027457; PMCID: PMC6283785.
Copy Download .nbib Format: NLM
Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13.

Frontiers in molecular neuroscience

Falvella ACB, Smith BJ, Silva-Costa LC, Valença AGF, Crunfli F, Zuardi AW, Hallak JE, Crippa JA, de Almeida V, Martins-de-Souza D.
PMID: 34122009
Front Mol Neurosci. 2021 May 28;14:673144. doi: 10.3389/fnmol.2021.673144. eCollection 2021.

Cannabidiol, a compound of

Cite
Falvella ACB, Smith BJ, Silva-Costa LC, et al. Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021;14:673144doi: 10.3389/fnmol.2021.673144.
Falvella, A. C. B., Smith, B. J., Silva-Costa, L. C., Valença, A. G. F., Crunfli, F., Zuardi, A. W., Hallak, J. E., Crippa, J. A., de Almeida, V., & Martins-de-Souza, D. (2021). Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Frontiers in molecular neuroscience, 14673144. https://doi.org/10.3389/fnmol.2021.673144
Falvella, Ana Caroline Brambilla, et al. "Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13." Frontiers in molecular neuroscience vol. 14 (2021): 673144. doi: https://doi.org/10.3389/fnmol.2021.673144
Falvella ACB, Smith BJ, Silva-Costa LC, Valença AGF, Crunfli F, Zuardi AW, Hallak JE, Crippa JA, de Almeida V, Martins-de-Souza D. Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021 May 28;14:673144. doi: 10.3389/fnmol.2021.673144. eCollection 2021. PMID: 34122009; PMCID: PMC8193732.
Copy Download .nbib Format: NLM
Improvement of antidepressant-induced sweating with as-required benztropine.

Innovations in clinical neuroscience

Kolli V, Ramaswamy S.
PMID: 24563813
Innov Clin Neurosci. 2013 Nov;10(11):10-1.

No abstract available.

Cite
Kolli V, Ramaswamy S. Improvement of antidepressant-induced sweating with as-required benztropine. Innov Clin Neurosci. 2013;10(11):10-1
Kolli, V., & Ramaswamy, S. (2013). Improvement of antidepressant-induced sweating with as-required benztropine. Innovations in clinical neuroscience, 10(11), 10-1.
Kolli, Venkata, and Ramaswamy, Sriram. "Improvement of antidepressant-induced sweating with as-required benztropine." Innovations in clinical neuroscience vol. 10,11 (2013): 10-1.
Kolli V, Ramaswamy S. Improvement of antidepressant-induced sweating with as-required benztropine. Innov Clin Neurosci. 2013 Nov;10(11):10-1. PMID: 24563813; PMCID: PMC3931183.
Copy Download .nbib Format: NLM
Evaluation of Ebola Virus Inhibitors for Drug Repurposing.

ACS infectious diseases

Madrid PB, Panchal RG, Warren TK, Shurtleff AC, Endsley AN, Green CE, Kolokoltsov A, Davey R, Manger ID, Gilfillan L, Bavari S, Tanga MJ.
PMID: 27622822
ACS Infect Dis. 2015 Jul 10;1(7):317-26. doi: 10.1021/acsinfecdis.5b00030. Epub 2015 May 11.

A systematic screen of FDA-approved drugs was performed to identify compounds with in vitro antiviral activities against Ebola virus (EBOV). Compounds active (>50% viral inhibition and

Cite
Madrid PB, Panchal RG, Warren TK, et al. Evaluation of Ebola Virus Inhibitors for Drug Repurposing. ACS Infect Dis. 2015;1(7):317-26doi: 10.1021/acsinfecdis.5b00030.
Madrid, P. B., Panchal, R. G., Warren, T. K., Shurtleff, A. C., Endsley, A. N., Green, C. E., Kolokoltsov, A., Davey, R., Manger, I. D., Gilfillan, L., Bavari, S., & Tanga, M. J. (2015). Evaluation of Ebola Virus Inhibitors for Drug Repurposing. ACS infectious diseases, 1(7), 317-26. https://doi.org/10.1021/acsinfecdis.5b00030
Madrid, Peter B, et al. "Evaluation of Ebola Virus Inhibitors for Drug Repurposing." ACS infectious diseases vol. 1,7 (2015): 317-26. doi: https://doi.org/10.1021/acsinfecdis.5b00030
Madrid PB, Panchal RG, Warren TK, Shurtleff AC, Endsley AN, Green CE, Kolokoltsov A, Davey R, Manger ID, Gilfillan L, Bavari S, Tanga MJ. Evaluation of Ebola Virus Inhibitors for Drug Repurposing. ACS Infect Dis. 2015 Jul 10;1(7):317-26. doi: 10.1021/acsinfecdis.5b00030. Epub 2015 May 11. PMID: 27622822.
Copy Download .nbib Format: NLM
Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13.

Frontiers in molecular neuroscience

Falvella ACB, Smith BJ, Silva-Costa LC, Valença AGF, Crunfli F, Zuardi AW, Hallak JE, Crippa JA, de Almeida V, Martins-de-Souza D.
PMID: 34122009
Front Mol Neurosci. 2021 May 28;14:673144. doi: 10.3389/fnmol.2021.673144. eCollection 2021.

Cannabidiol, a compound of

Cite
Falvella ACB, Smith BJ, Silva-Costa LC, et al. Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021;14:673144doi: 10.3389/fnmol.2021.673144.
Falvella, A. C. B., Smith, B. J., Silva-Costa, L. C., Valença, A. G. F., Crunfli, F., Zuardi, A. W., Hallak, J. E., Crippa, J. A., de Almeida, V., & Martins-de-Souza, D. (2021). Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Frontiers in molecular neuroscience, 14673144. https://doi.org/10.3389/fnmol.2021.673144
Falvella, Ana Caroline Brambilla, et al. "Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13." Frontiers in molecular neuroscience vol. 14 (2021): 673144. doi: https://doi.org/10.3389/fnmol.2021.673144
Falvella ACB, Smith BJ, Silva-Costa LC, Valença AGF, Crunfli F, Zuardi AW, Hallak JE, Crippa JA, de Almeida V, Martins-de-Souza D. Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021 May 28;14:673144. doi: 10.3389/fnmol.2021.673144. eCollection 2021. PMID: 34122009; PMCID: PMC8193732.
Copy Download .nbib Format: NLM
Acute chorea due to ondansetron in an obstetric patient.

International journal of obstetric anesthesia

Duncan MA, Nikolov NM, O'Kelly B.
PMID: 15321589
Int J Obstet Anesth. 2001 Oct;10(4):309-11. doi: 10.1054/ijoa.2001.0860.

This case describes a 34-year-old female who developed severe chorea following intravenous administration of ondansetron after elective caesarean section under spinal anaesthesia. A course of benztropine led to a decrease in severity of the reaction which resolved on the...

Cite
Duncan MA, Nikolov NM, O'Kelly B. Acute chorea due to ondansetron in an obstetric patient. Int J Obstet Anesth. 2001;10(4):309-11doi: 10.1054/ijoa.2001.0860.
Duncan, M. A., Nikolov, N. M., & O'Kelly, B. (2001). Acute chorea due to ondansetron in an obstetric patient. International journal of obstetric anesthesia, 10(4), 309-11. https://doi.org/10.1054/ijoa.2001.0860
Duncan, M A, et al. "Acute chorea due to ondansetron in an obstetric patient." International journal of obstetric anesthesia vol. 10,4 (2001): 309-11. doi: https://doi.org/10.1054/ijoa.2001.0860
Duncan MA, Nikolov NM, O'Kelly B. Acute chorea due to ondansetron in an obstetric patient. Int J Obstet Anesth. 2001 Oct;10(4):309-11. doi: 10.1054/ijoa.2001.0860. PMID: 15321589.
Copy Download .nbib Format: NLM
The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection.

The mental health clinician

Stump TA, Nelson LA, Liu Y, Kriz CR, Iuppa CA, Diefenderfer LA, Lang SE, Elliot ESR, Sommi RW.
PMID: 33505820
Ment Health Clin. 2021 Jan 08;11(1):12-18. doi: 10.9740/mhc.2021.01.012. eCollection 2021 Jan.

INTRODUCTION: Dosing recommendations for paliperidone long-acting injectable antipsychotic (LAIA) do not include oral antipsychotic (OAP) overlap; however, OAPs are often given concurrently despite limited evidence describing both the risks and benefits of this practice.METHODS: A retrospective chart review was...

Cite
Stump TA, Nelson LA, Liu Y, et al. The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection. Ment Health Clin. 2021;11(1):12-18doi: 10.9740/mhc.2021.01.012.
Stump, T. A., Nelson, L. A., Liu, Y., Kriz, C. R., Iuppa, C. A., Diefenderfer, L. A., Lang, S. E., Elliot, E. S. R., & Sommi, R. W. (2021). The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection. The mental health clinician, 11(1), 12-18. https://doi.org/10.9740/mhc.2021.01.012
Stump, Trevor A, et al. "The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection." The mental health clinician vol. 11,1 (2021): 12-18. doi: https://doi.org/10.9740/mhc.2021.01.012
Stump TA, Nelson LA, Liu Y, Kriz CR, Iuppa CA, Diefenderfer LA, Lang SE, Elliot ESR, Sommi RW. The effects of concurrent oral paliperidone or risperidone use with paliperidone long-acting injection. Ment Health Clin. 2021 Jan 08;11(1):12-18. doi: 10.9740/mhc.2021.01.012. eCollection 2021 Jan. PMID: 33505820; PMCID: PMC7800326.
Copy Download .nbib Format: NLM
Unprovoked Dystonic Reaction in a Child Taking Long-Term Methylphenidate.

Journal of pharmacy practice

Pagliaro A, Mattio B, Paulson N, Fromm C, Vidal J.
PMID: 33813918
J Pharm Pract. 2021 Apr 05;897190021999781. doi: 10.1177/0897190021999781. Epub 2021 Apr 05.

In this report, we discuss the case of a 9-year-old male with Attention Deficit Hyperactivity Disorder (ADHD) on long-term methylphenidate and guanfacine who experienced acute orofacial dystonia that resolved immediately with the administration of benztropine. Current literature describes various...

Cite
Pagliaro A, Mattio B, Paulson N, et al. Unprovoked Dystonic Reaction in a Child Taking Long-Term Methylphenidate. J Pharm Pract. 2021;897190021999781doi: 10.1177/0897190021999781.
Pagliaro, A., Mattio, B., Paulson, N., Fromm, C., & Vidal, J. (2021). Unprovoked Dystonic Reaction in a Child Taking Long-Term Methylphenidate. Journal of pharmacy practice, 897190021999781. https://doi.org/10.1177/0897190021999781
Pagliaro, Alyssa, et al. "Unprovoked Dystonic Reaction in a Child Taking Long-Term Methylphenidate." Journal of pharmacy practice vol. (2021): 897190021999781. doi: https://doi.org/10.1177/0897190021999781
Pagliaro A, Mattio B, Paulson N, Fromm C, Vidal J. Unprovoked Dystonic Reaction in a Child Taking Long-Term Methylphenidate. J Pharm Pract. 2021 Apr 05;897190021999781. doi: 10.1177/0897190021999781. Epub 2021 Apr 05. PMID: 33813918.
Copy Download .nbib Format: NLM
Use of Selective Serotonin Reuptake Inhibitor and Midodrine in a Patient With Autonomic Instability 2/2 Compressive Squamous Cell Carcinoma and Pain.

Journal of investigative medicine high impact case reports

Ball K, Vacek TP.
PMID: 29404375
J Investig Med High Impact Case Rep. 2018 Jan 29;6:2324709617749621. doi: 10.1177/2324709617749621. eCollection 2018.

A rare cause of reflex syncope is metastatic cancers involving the head and neck. These can irritate the glossopharyngeal nerve and lead to glossopharyngeal neuralgia with associated syncope. This type of syncope is difficult to treat since it commonly...

Cite
Ball K, Vacek TP. Use of Selective Serotonin Reuptake Inhibitor and Midodrine in a Patient With Autonomic Instability 2/2 Compressive Squamous Cell Carcinoma and Pain. J Investig Med High Impact Case Rep. 2018;6:2324709617749621doi: 10.1177/2324709617749621.
Ball, K., & Vacek, T. P. (2018). Use of Selective Serotonin Reuptake Inhibitor and Midodrine in a Patient With Autonomic Instability 2/2 Compressive Squamous Cell Carcinoma and Pain. Journal of investigative medicine high impact case reports, 62324709617749621. https://doi.org/10.1177/2324709617749621
Ball, Kyle, and Vacek, Thomas P. "Use of Selective Serotonin Reuptake Inhibitor and Midodrine in a Patient With Autonomic Instability 2/2 Compressive Squamous Cell Carcinoma and Pain." Journal of investigative medicine high impact case reports vol. 6 (2018): 2324709617749621. doi: https://doi.org/10.1177/2324709617749621
Ball K, Vacek TP. Use of Selective Serotonin Reuptake Inhibitor and Midodrine in a Patient With Autonomic Instability 2/2 Compressive Squamous Cell Carcinoma and Pain. J Investig Med High Impact Case Rep. 2018 Jan 29;6:2324709617749621. doi: 10.1177/2324709617749621. eCollection 2018. PMID: 29404375; PMCID: PMC5791471.
Copy Download .nbib Format: NLM
Low heart rate variability is not caused by typical neuroleptics in schizophrenia patients.

CNS spectrums

Malaspina D, Dalack G, Leitman D, Corcoran C, Amador XF, Yale S, Glassman A, Gorman JM.
PMID: 15254449
CNS Spectr. 2002 Jan;7(1):53-7. doi: 10.1017/s1092852900022264.

Both elevated cardiovascular mortality and low cardio-vagal (parasympathetic) heart rate variability (HRV)--a risk factor for postmyocardial infarction--are reported in schizophrenia (SZ). Since a number of medications have strong effects of cardiac conductivity, we thought it important to examine if...

Cite
Malaspina D, Dalack G, Leitman D, et al. Low heart rate variability is not caused by typical neuroleptics in schizophrenia patients. CNS Spectr. 2002;7(1):53-7doi: 10.1017/s1092852900022264.
Malaspina, D., Dalack, G., Leitman, D., Corcoran, C., Amador, X. F., Yale, S., Glassman, A., & Gorman, J. M. (2002). Low heart rate variability is not caused by typical neuroleptics in schizophrenia patients. CNS spectrums, 7(1), 53-7. https://doi.org/10.1017/s1092852900022264
Malaspina, Dolores, et al. "Low heart rate variability is not caused by typical neuroleptics in schizophrenia patients." CNS spectrums vol. 7,1 (2002): 53-7. doi: https://doi.org/10.1017/s1092852900022264
Malaspina D, Dalack G, Leitman D, Corcoran C, Amador XF, Yale S, Glassman A, Gorman JM. Low heart rate variability is not caused by typical neuroleptics in schizophrenia patients. CNS Spectr. 2002 Jan;7(1):53-7. doi: 10.1017/s1092852900022264. PMID: 15254449.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 22 entries